Keyphrases
Taiwan
100%
Atrial Fibrillation
85%
Catheter Ablation
51%
Confidence Interval
38%
Hepatocellular Carcinoma
37%
Hazard Ratio
33%
Clinical Outcomes
31%
Hypertension
30%
Risk Factors
26%
Atrial Fibrillation Ablation
24%
Heart Failure
23%
Paroxysmal Atrial Fibrillation
23%
Ablation
22%
National Cohort Study
21%
Ventricular Arrhythmia
21%
Blood Pressure
20%
Asia
17%
Taiwanese
17%
Hemodialysis Patients
17%
Cirrhosis
16%
All-cause Mortality
15%
Hypertension Management
15%
Cardiovascular Mortality
15%
Odds Ratio
15%
Pulmonary Vein Isolation
15%
Pulmonary Vein
14%
Multivariate Analysis
14%
High Risk
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Atrial Substrate
14%
Prognostic Factors
14%
Ca2+
14%
Overall Survival
14%
Systolic Blood Pressure
13%
Type 2 Diabetic Patients
13%
Left Atrium
13%
Portal Hypertension
13%
Southern Taiwan
13%
Systemic Lupus Erythematosus
12%
Meta-analysis
12%
Liver Cirrhosis
12%
Atrial Fibrillation Recurrence
12%
Heart Failure with Preserved Ejection Fraction (HFpEF)
11%
Rheumatoid Arthritis
11%
Persistent Atrial Fibrillation
11%
Cardiovascular Risk
11%
Clinical Characteristics
11%
Electrophysiological Characteristics
11%
Hemodialysis
11%
Radiofrequency Ablation
10%
Taiwan Society of Cardiology
10%
Randomized Controlled Trial
10%
Chronic Kidney Disease
10%
Central Blood Pressure
10%
Left Ventricular Ejection Fraction
10%
CHA2DS2-VASc Score
10%
Left Atrial
10%
Type 1 Diabetes Mellitus (T1DM)
9%
Chemotherapy
9%
SHP-1
9%
Liver
9%
Hepatocellular Carcinoma Patients
9%
Cirrhotic Patients
9%
Metabolic Syndrome
9%
Diabetes
9%
End-stage Renal Disease
9%
Clinical Significance
8%
Percutaneous Coronary Intervention
8%
Cardiovascular Disease
8%
Coronary Artery Disease
8%
Body Mass Index
8%
Ventricular Tachycardia
8%
Induced Apoptosis
8%
General Hospital
8%
Systematic Meta-analysis
8%
High Incidence
8%
COVID-19
8%
Des-acyl Ghrelin
8%
Medical Center
8%
Patients with Heart Failure
8%
Acute Heart Failure
8%
Tumor Necrosis Factor-α
8%
Sacubitril-valsartan
8%
Apoptosis
8%
Sinus Rhythm
7%
Intensive Care Unit
7%
Electrogram
7%
Arrhythmogenic Right Ventricular Cardiomyopathy
7%
Portal Hypertensive
7%
Myocardial Infarction
7%
Low Risk
7%
Portal Pressure
7%
Asian Patients
7%
Albumin-bilirubin Grade
7%
Cardiovascular Events
7%
Ischemic Stroke
7%
Medical Students
7%
Dominant Frequency
7%
High Prevalence
7%
Comorbidity
7%
Medicine and Dentistry
Atrial Fibrillation
81%
Ablation
56%
Hepatocellular Carcinoma
37%
Blood Pressure
36%
Cardiovascular System
31%
Congestive Heart Failure
28%
Diseases
27%
Recurrent Disease
26%
Hazard Ratio
26%
Liver Cirrhosis
25%
Cohort Analysis
25%
Apoplexy
23%
Prevalence
22%
Paroxysmal Atrial Fibrillation
20%
Hemodialysis
17%
Neoplasm
17%
Ventricular Tachycardia
16%
Cardiovascular Disease
16%
Hemodynamic
15%
Pulmonary Vein
15%
Pulmonary Vein Isolation
14%
Systolic Blood Pressure
14%
Infection
13%
Cardiology
13%
Heart Ventricle Arrhythmia
13%
Overall Survival
13%
Pulse Wave Velocity
12%
Diabetes Mellitus
12%
Electrography
12%
Coronary Artery Disease
12%
Left Atrium
12%
Prognostic Factor
11%
Chronic Kidney Disease
11%
Maturity Onset Diabetes of the Young
11%
End Stage Renal Disease
11%
Breast Cancer
11%
Odds Ratio
10%
Arrhythmogenic Right Ventricular Dysplasia
10%
Diabetes
10%
Multivariate Analysis
10%
Proportional Hazards Model
10%
Portal Hypertension
10%
Systemic Lupus Erythematosus
9%
Cardiovascular Risk
9%
Antithrombotic
9%
COVID-19
9%
Randomized Controlled Trial
9%
All Cause Mortality
9%
Meta-Analysis
9%
Supraventricular Tachycardia
9%
Radiofrequency Ablation
9%
Persistent Atrial Fibrillation
8%
Malignant Neoplasm
8%
Intensive Care Unit
8%
Atrial Fibrillation Ablation
8%
Blood Pressure Monitoring
8%
Atrial Flutter
7%
Bilirubin
7%
CHA2DS2-VASc Score
7%
Adverse Event
7%
Rheumatoid Arthritis
7%
Inflammatory Arthritis
7%
Sinus Rhythm
7%
Ablation Therapy
7%
Electrocardiogram
7%
Body Mass Index
7%
Angiogenesis
7%
Surgery
7%
Brain Ischemia
7%
Percutaneous Coronary Intervention
7%
Observational Study
7%
Myocardial Disease
7%
Heart Left Ventricle Ejection Fraction
7%
Diagnosis
7%
Kidney Function
7%
Human Immunodeficiency Virus
7%
Mortality Rate
7%
Patient with Type 2 Diabetes
7%
Myocardial Infarction
6%
Acute Decompensated Heart Failure
6%
Tumor Necrosis Factor
6%
Peritoneal Dialysis
6%
Cancer
6%
Transcatheter Arterial Chemoembolization
6%
Risk Stratification
6%
Cardiovascular Mortality
6%
Systematic Review
6%
Heart Failure with Reduced Ejection Fraction
6%
Retrospective Study
6%
C Reactive Protein
6%
Platelet
6%
Portal Venous Pressure
6%
Ejection Fraction
6%
Ghrelin
6%
Pulse Rate
6%
Bleeding
6%
Sudden Cardiac Death
6%
Hepatitis B Virus
6%
Fibrosis
6%
Comorbidity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
57%
Liver Cell Carcinoma
41%
Congestive Heart Failure
33%
Diseases
31%
Cohort Study
30%
Prevalence
23%
Hemodialysis
20%
Recurrent Disease
20%
Cerebrovascular Accident
20%
Liver Cirrhosis
19%
Cardiovascular Disease
18%
Infection
16%
Neoplasm
13%
Diabetes Mellitus
13%
Overall Survival
13%
Non Insulin Dependent Diabetes Mellitus
13%
Calcium Ion
12%
Rheumatoid Arthritis
12%
Inflammatory Arthritis
12%
Chemotherapy
12%
Heart Ventricle Arrhythmia
12%
All Cause Mortality
11%
Adverse Event
11%
Paroxysmal Atrial Fibrillation
11%
Inflammation
11%
Coronary Artery Disease
11%
Chronic Kidney Failure
11%
Breast Cancer
10%
Anticoagulant Agent
10%
Portal Hypertension
10%
Colorectal Carcinoma
10%
End Stage Renal Disease
10%
Randomized Controlled Trial
9%
Malignant Neoplasm
9%
Hepatitis B Virus
9%
Heart Right Ventricle Dysplasia
9%
Tumor Necrosis Factor
8%
Sorafenib
8%
Observational Study
8%
Heart Ventricle Tachycardia
8%
Combination Therapy
8%
Bilirubin
8%
Creatinine
8%
Nonalcoholic Fatty Liver
7%
Valsartan/Sacubitril
7%
C Reactive Protein
7%
Myocardial Disease
7%
Metabolic Syndrome X
7%
Cardiovascular Risk
7%
Brain Ischemia
7%
Systemic Lupus Erythematosus
7%
Heart Failure with Reduced Ejection Fraction
7%
HIV
7%
Remission
6%
Mortality Rate
6%
Syndrome
6%
Chronic Hepatitis B
6%
Heart Infarction
6%
Comorbidity
6%
Adult Respiratory Distress Syndrome
6%
Cytokine
6%
Carbapenem
5%
Cardiovascular Mortality
5%
Progression Free Survival
5%
Retrospective Study
5%
Antihypertensive Agent
5%
Heart Arrhythmia
5%
Placebo
5%
Receptor
5%
Kidney Disease
5%
Arteriovenous Fistula
5%
Ghrelin
5%
Liver Fibrosis
5%
Biological Marker
5%
Warfarin
5%